Researchers found molecular alterations in alcoholism causing impaired executive control and alcohol craving. Preclinical research showed psychedelics restored molecular deficits and reduced relapse behaviour.
A study by the University of Buenos Aires suggests the importance of investigating the effects of psychedelic drugs in the contexts in which they are naturally consumed, in order to obtain less artificial results.
The results of a study in healthy volunteers presented by Dr. Anna Becker suggest that SSRIs should not be discontinued prior to psilocybin treatment.
Dr. Anna Ciaunica gave an insight into her work at the INSIGHT 2021 Conference and explained how the COVID-19 crisis-induced lack of tactile experience favours a depersonalitation disorder.
Psychedelic therapy and psychotherapy - differences and similarities and potential problems for therapists. Prof. Matthew Johnson (Johns Hopkins University) shared his work at the INSIGHT 2021 Conference.
Psychedelics could represent a new treatment approach in psychiatry. But can they combat the global health crisis? At the INSIGHT 2021 Conference, Prof. Dr. Gerhard Gründer takes a critical look on the issue.
For neuroscientist Dr. Martha Havenith, psychedelics are not the only way to explore altered states of consciousness. She works with voluntary hyperventilation (Breathwork) to achieve different perceptions.
In parts of public discourse and scientific literature, psychedelic therapies are claimed to transform and revolutionise psychiatry and mental healthcare. Can psychedelics live up to this claim?
The 2021 edition will cover treatment, basic research, philosophy/anthropology, and implementation of the clinical applications and emerging trends in the field of psychedelic treatments.
The method is called "Augmented Psychotherapy" and shows how depression can be treated when psychotherapy and psychopharmacology are combined.